Editorial Board
Pharmacognosy Reviews is guided by an independent international board. All submissions are handled by a section editor with no conflict of interest and reviewed under a double-anonymized policy.
Dr. Ahmed M
Tsinghua University, China
Pharmacognosy Reviews is published Semi-annual, serves the need of different scientists and others involved in medicinal plant research and development. Each issue covers different reviews on related topics of natural product drug discovery, Biotechnology, Marine Pharmacognosy and Medicinal Plants. Review articles that are of broad readership interest to users in industry, academia, and government. Phcog Rev. is an important and most cited review journal for medicinal Plant researchers —and it's an Open Access Publication. Editorial correspondence and appeals may be addressed to the Editor-in-Chief through the submission system.
Senior Editorial Team
3 membersSets editorial policy, arbitrates appeals and oversees the double-anonymized review process.
- Deputy Editor
Lars Yamada
University of Melbourne, Australia
- Deputy Editor
Chidi Osei
Sorbonne Université, France
- Ethics & Integrity Editor
Wei Reyes
University of Cape Town, South Africa
Research integrity, retractions
Associate Editors
0 membersOne handling editor per section, responsible for reviewer selection and decisions.
Advisory Board
Serving on the board
Associate editors serve renewable three-year terms. Nominations, including self- nominations from active reviewers of Pharmacogn. Rev., are reviewed twice a year by the senior editorial team.